rs3864004
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000431914.6(CTNNB1):c.-144G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.397 in 152,228 control chromosomes in the GnomAD database, including 12,372 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 12368 hom., cov: 34)
Exomes 𝑓: 0.43 ( 4 hom. )
Consequence
CTNNB1
ENST00000431914.6 5_prime_UTR
ENST00000431914.6 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.00600
Publications
35 publications found
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
- exudative vitreoretinopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- severe intellectual disability-progressive spastic diplegia syndromeInheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
- exudative vitreoretinopathy 7Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.449 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTNNB1 | ENST00000431914.6 | c.-144G>A | 5_prime_UTR_variant | Exon 1 of 16 | 4 | ENSP00000412219.2 | ||||
| CTNNB1 | ENST00000642992.1 | c.-144G>A | 5_prime_UTR_variant | Exon 1 of 15 | ENSP00000496385.1 | |||||
| CTNNB1 | ENST00000405570.6 | c.-49+2980G>A | intron_variant | Intron 2 of 16 | 2 | ENSP00000385604.1 |
Frequencies
GnomAD3 genomes AF: 0.397 AC: 60332AN: 152066Hom.: 12366 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
60332
AN:
152066
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.432 AC: 19AN: 44Hom.: 4 Cov.: 0 AF XY: 0.423 AC XY: 11AN XY: 26 show subpopulations
GnomAD4 exome
AF:
AC:
19
AN:
44
Hom.:
Cov.:
0
AF XY:
AC XY:
11
AN XY:
26
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
2
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
13
AN:
34
Other (OTH)
AF:
AC:
4
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.397 AC: 60361AN: 152184Hom.: 12368 Cov.: 34 AF XY: 0.393 AC XY: 29237AN XY: 74384 show subpopulations
GnomAD4 genome
AF:
AC:
60361
AN:
152184
Hom.:
Cov.:
34
AF XY:
AC XY:
29237
AN XY:
74384
show subpopulations
African (AFR)
AF:
AC:
13244
AN:
41542
American (AMR)
AF:
AC:
5557
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
1326
AN:
3470
East Asian (EAS)
AF:
AC:
1286
AN:
5160
South Asian (SAS)
AF:
AC:
1936
AN:
4822
European-Finnish (FIN)
AF:
AC:
4856
AN:
10568
Middle Eastern (MID)
AF:
AC:
110
AN:
294
European-Non Finnish (NFE)
AF:
AC:
30828
AN:
67992
Other (OTH)
AF:
AC:
822
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1926
3852
5779
7705
9631
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1260
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.